亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

肺炎克雷伯菌 医学 内科学 克雷伯菌 前瞻性队列研究 碳青霉烯 队列 队列研究 抗生素 微生物学 生物 大肠杆菌 生物化学 基因
作者
Minggui Wang,Michelle Earley,Liang Chen,Blake Hanson,Yunsong Yu,Zhengyin Liu,Soraya Salcedo,Eric Cober,Lanjuan Li,Souha S. Kanj,Hainv Gao,José M. Munita,Karen Ordóñez,Greg Weston,Michael J. Satlin,Sandra Valderrama,Kalisvar Marimuthu,Martín E. Stryjewski,Lauren Komarow,Courtney Luterbach
出处
期刊:Lancet Infectious Diseases [Elsevier BV]
卷期号:22 (3): 401-412 被引量:338
标识
DOI:10.1016/s1473-3099(21)00399-6
摘要

Background Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a global threat. We therefore analysed the bacterial characteristics of CRKP infections and the clinical outcomes of patients with CRKP infections across different countries. Methods In this prospective, multicentre, cohort study (CRACKLE-2), hospitalised patients with cultures positive for CRKP were recruited from 71 hospitals in Argentina, Australia, Chile, China, Colombia, Lebanon, Singapore, and the USA. The first culture positive for CRKP was included for each unique patient. Clinical data on post-hospitalisation death and readmission were collected from health records, and whole genome sequencing was done on all isolates. The primary outcome was a desirability of outcome ranking at 30 days after the index culture, and, along with bacterial characteristics and 30-day all-cause mortality (a key secondary outcome), was compared between patients from China, South America, and the USA. The desirability of outcome ranking was adjusted for location before admission, Charlson comorbidity index, age at culture, Pitt bacteremia score, and anatomical culture source through inverse probability weighting; mortality was adjusted for the same confounders, plus region where relevant, through multivariable logistic regression. This study is registered at ClinicalTrials.gov, NCT03646227, and is complete. Findings Between June 13, 2017, and Nov 30, 2018, 991 patients were enrolled, of whom 502 (51%) met the criteria for CRKP infection and 489 (49%) had positive cultures that were considered colonisation. We observed little intra-country genetic variation in CRKP. Infected patients from the USA were more acutely ill than were patients from China or South America (median Pitt bacteremia score 3 [IQR 2–6] vs 2 [0–4] vs 2 [0–4]) and had more comorbidities (median Charlson comorbidity index 3 [IQR 2–5] vs 1 [0–3] vs 1 [0–2]). Adjusted desirability of outcome ranking outcomes were similar in infected patients from China (n=246), South America (n=109), and the USA (n=130); the estimates were 53% (95% CI 42–65) for China versus South America, 50% (41–61) for the USA versus China, and 53% (41–66) for the USA versus South America. In patients with CRKP infections, unadjusted 30-day mortality was lower in China (12%, 95% CI 8–16; 29 of 246) than in the USA (23%, 16–30; 30 of 130) and South America (28%, 20–37; 31 of 109). Adjusted 30-day all-cause mortality was higher in South America than in China (adjusted odds ratio [aOR] 4·82, 95% CI 2·22–10·50) and the USA (aOR 3·34, 1·50–7·47), with the mortality difference between the USA and China no longer being significant (aOR 1·44, 0·70–2·96). Interpretation Global CRKP epidemics have important regional differences in patients' baseline characteristics and clinical outcomes, and in bacterial characteristics. Research findings from one region might not be generalisable to other regions. Funding The National Institutes of Health.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小梁发布了新的文献求助10
2秒前
NexusExplorer的应助被1874采纳,获得10
7秒前
研友_nxw2xL完成签到,获得积分0
11秒前
科研通AI6.3的应助被萧雨墨采纳,获得10
11秒前
31秒前
科研通AI65的应助被萧雨墨采纳,获得10
34秒前
张阳发布了新的文献求助10
36秒前
41秒前
41秒前
41秒前
复杂的万恶完成签到,获得积分10
43秒前
认真的龙猫完成签到 ,获得积分10
45秒前
50秒前
贱小贱完成签到,获得积分0
50秒前
me6363发布了新的文献求助10
55秒前
139完成签到 ,获得积分10
1分钟前
无极微光的应助被行必至采纳,获得20
1分钟前
科研通AI6.2的应助被萧雨墨采纳,获得10
1分钟前
飘逸的安珊完成签到,获得积分10
1分钟前
1分钟前
飞快的不尤完成签到,获得积分10
1分钟前
Jazz33333333完成签到,获得积分10
1分钟前
1874发布了新的文献求助10
1分钟前
shentaii完成签到,获得积分0
1分钟前
果枳完成签到,获得积分10
1分钟前
行必至完成签到,获得积分20
1分钟前
萧雨墨发布了新的文献求助10
2分钟前
香蕉觅云的应助被1874采纳,获得10
2分钟前
张阳发布了新的文献求助10
2分钟前
萧雨墨发布了新的文献求助10
2分钟前
情怀的应助被Lihedou采纳,获得10
2分钟前
2分钟前
2分钟前
Lihedou发布了新的文献求助10
2分钟前
萧雨墨发布了新的文献求助10
2分钟前
Maestro_S的应助被abc采纳,获得10
2分钟前
2分钟前
Jun的应助被科研通管家采纳,获得10
2分钟前
2分钟前
Jun的应助被科研通管家采纳,获得10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190127
求助须知:如何正确求助?哪些是违规求助? 9577222
关于积分的说明 21852177
捐赠科研通 7788440
什么是DOI,文献DOI怎么找? 3436259
关于科研通互助平台的介绍 2559994
邀请新用户注册赠送积分活动 2482880